REG - Dr. Martens PLC - Technical change in Permira ownership structure

Dr MartensAnnouncement

12/06/2024 16:45

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240612:nRSL2034Sa&default-theme=true

RNS Number : 2034S  Dr. Martens PLC  12 June 2024

 

12 June 2024

Dr. Martens plc

 

Technical change in Permira ownership structure

 

Dr. Martens plc ('the Company') makes this announcement in connection with the
TR-1 announcements released today regarding the notification of major holdings
by IngreGrsy Limited and IngreLux S.àr.l..

Permira V Fund has undergone a restructure of its holding of shares in Dr.
Martens plc, whereby IngreGrsy Limited (a newly incorporated Guernsey company)
has replaced IngreLux S.àr.l. (a Luxembourg entity) in the Permira Fund V
structure and IngreLux S.àr.l has transferred its 38.46% shareholding in the
Company to IngreGrsy Limited.  As a result, IngreGrsy Limited replaced
IngreLux S.àr.l. as the Company's largest shareholder with effect from 11
June 2024. The Company, IngreLux S.àr.l. and IngreGrsy Limited also entered
into a novation agreement in order for IngreGrsy Limited to replace IngreLux
S.à r.l. in the relationship agreement with the Company.  The Permira V Fund
ownership structure is otherwise unchanged and remains ultimately controlled
by Permira V GP Limited and advised by Permira Advisers LLP.

 

 

Enquiries

Investors and analysts
 

Bethany Barnes, Director of Investor Relations
Bethany.Barnes@drmartens.com (mailto:Bethany.Barnes@drmartens.com)    +44
7825 187465

Beth Callum, Investor Relations Manager  Beth.Callum@drmartens.com
(mailto:Beth.Callum@drmartens.com)
                +44 203 995 2644

 

Company Secretariat

Paul Rolling, Assistant Company Secretary   Paul.Rolling@drmartens.com
(mailto:Paul.Rolling@drmartens.com)

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCQKBBNPBKDBAD